SEARCH

SEARCH BY CITATION

References

  • 1
    Centers for Disease Control and Prevention. National Diabetes Fact Sheet: general information and national estimates on diabetes in the United States, 2007. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease and Prevention, 2008.
  • 2
    Campbell RK, Martin TM. The chronic burden of diabetes. Am J Manag Care 2009;15:S248S254.
  • 3
    Ford ES, Williamson DF, Liu S. Weight change and diabetes incidence: findings from a national cohort of US adults. Am J Epidemiol 1997;146:214222.
  • 4
    Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995;122:481486.
  • 5
    Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999–2008. JAMA 2010;303:235241.
  • 6
    Cawley, J, Rizzo, J, Gunnarsson, C, Haas, K. The health care cost effects of diabetes among obese and morbidly obese adults in the United States. Poster presented at International Society of Pharmacoeconomic Outcomes Research (ISPOR) 13th Annual International meeting, Toronto, ON, Canada.
  • 7
    Wing RR, Koeske R, Epstein LH et al. Long-term effects of modest weight loss in type II diabetic patients. Arch Intern Med 1987;147:17491753.
  • 8
    Pories WJ, Swanson MS, MacDonald KG et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995;222:339350; discussion 350.
  • 9
    Dixon JB, O'Brien PE, Playfair J et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 2008;299:316323.
  • 10
    Schauer PR, Ikramuddin S, Gourash W, Ramanathan R, Luketich J. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg 2000;232:515529.
  • 11
    Pladevall M, Williams LK, Potts LA et al. Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care 2004;27:28002805.
  • 12
    Cremieux PY, Buchwald H, Shikora SA et al. A study on the economic impact of bariatric surgery. Am J Manag Care 2008;14:589596.
  • 13
    American Society for Bariatric Surgery Web site. Guidelines for Granting Privileges in Bariatric Surgery. <http:www.asbs.orghtmlguidelines.html>. Accessed 15 August 2007.
  • 14
    Finkelstein EA, Brown DS. A cost-benefit simulation model of coverage for bariatric surgery among full-time employees. Am J Manag Care 2005;11:641646.
  • 15
    Snow LL, Weinstein LS, Hannon JK et al. The effect of Roux-en-Y gastric bypass on prescription drug costs. Obes Surg 2004;14:10311035.
  • 16
    Gould JC, Garren MJ, Starling JR. Laparoscopic gastric bypass results in decreased prescription medication costs within 6 months. J Gastrointest Surg 2004;8:983987.
  • 17
    Monk JS Jr, Dia-Nagib N, Stehr W. Pharmaceutical savings after gastric bypass surgery. Obes Surg 2004;14:1315.
  • 18
    Nguyen NT, Varela JE, Sabio A et al. Reduction in prescription medication costs after laparoscopic gastric bypass. Am Surg 2006;72:853856.
  • 19
    Narbro K, Agren G, Jonsson E et al.; Swedish Obese Subjects Intervention Study. Pharmaceutical costs in obese individuals: comparison with a randomly selected population sample and long-term changes after conventional and surgical treatment: the SOS intervention study. Arch Intern Med 2002;162:20612069.
  • 20
    Sjöström L, Lindroos AK, Peltonen M et al.; Swedish Obese Subjects Study Scientific Group. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004;351:26832693.
  • 21
    Rogula T, Brethauer S, Chand B, Schauer P. Bariatric surgery may cure type 2 diabetes in some patients. <http:my.clevelandclinic.orgbariatric_surgeryDocumentsMicrosoft20Word2020Diabetes_pts_info2_response20to206020minutes.pdf>. Accessed 23 November 2009.
  • 22
    Czupryniak L, Strzelczyk J, Cypryk K et al. Gastric bypass surgery in severely obese type 1 diabetic patients. Diabetes Care 2004;27:25612562.
  • 23
    Buchwald H, Estok R, Fahrbach K et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009;122:248256.e5.
  • 24
    Segal JB, Clark JM, Shore AD et al. Prompt reduction in use of medications for comorbid conditions after bariatric surgery. Obes Surg 2009;19:16461656.
  • 25
    Hodo DM, Waller JL, Martindale RG, Fick DM. Medication use after bariatric surgery in a managed care cohort. Surg Obes Relat Dis 2008;4:601607.